Literature DB >> 27403608

Lipid-based Nutrient Supplements Do Not Affect Gut Bifidobacterium Microbiota in Malawian Infants: A Randomized Trial.

Juhani Aakko1, Łukasz Grześkowiak, Tiia Asukas, Eerika Päivänsäde, Kirsi-Maarit Lehto, Yue-Mei Fan, Charles Mangani, Kenneth Maleta, Per Ashorn, Seppo Salminen.   

Abstract

OBJECTIVES: The aim of the study was to assess the effect of nutritional supplementation with lipid-based nutrient supplements (LNS) and corn-soy blend flour on Bifidobacterium and Staphylococcus aureus gut microbiota composition in Malawian infants. In addition, the microbiota changes over time were characterized in the study infants.
METHODS: Healthy 6-month-old Malawian infants were randomly assigned to 1 of 4 intervention schemes for a 6-month period. Infants in the control group were not provided with any supplementary food. Infants in other 3 groups received either micronutrient-fortified corn-soy blend, micronutrient-fortified LNS with milk protein base, or micronutrient-fortified LNS with soy protein base between 6 and 12 months of age. Fecal bifidobacteria and S aureus gut microbiota at 6 and 12 months of age were analyzed by quantitative real-time polymerase chain reaction method.
RESULTS: There was no difference in change in bacterial prevalence or counts between the intervention groups during the 6-month study period. When looking at the total study population, higher counts of total bacteria (P = 0.028), Bifidobacterium genus (P = 0.027), B catenulatum (P = 0.031), and lower counts of B infantis (P < 0.001), B lactis (P < 0.001), B longum (P < 0.001), and S aureus (P < 0.001) were detected in the children's stools at 12 months rather than at 6 months of age.
CONCLUSIONS: The dietary supplementation did not have an effect on the Bifidobacterium and S aureus microbiota composition of the study infants. The fecal bifidobacterial diversity of the infants, however, changed toward a more adult-like microbiota profile within the observed time.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27403608     DOI: 10.1097/MPG.0000000000001333

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  5 in total

Review 1.  Surveying Gut Microbiome Research in Africans: Toward Improved Diversity and Representation.

Authors:  Ryan Brewster; Fiona B Tamburini; Edgar Asiimwe; Ovokeraye Oduaran; Scott Hazelhurst; Ami S Bhatt
Journal:  Trends Microbiol       Date:  2019-06-06       Impact factor: 17.079

2.  Preventive lipid-based nutrient supplements given with complementary foods to infants and young children 6 to 23 months of age for health, nutrition, and developmental outcomes.

Authors:  Jai K Das; Rehana A Salam; Yousaf Bashir Hadi; Sana Sadiq Sheikh; Afsah Z Bhutta; Zita Weise Prinzo; Zulfiqar A Bhutta
Journal:  Cochrane Database Syst Rev       Date:  2019-05-02

Review 3.  Iron Supplementation at the Crossroads of Nutrition and Gut Microbiota: The State of the Art.

Authors:  Ana M Puga; María de Lourdes Samaniego-Vaesken; Ana Montero-Bravo; Mar Ruperto; Teresa Partearroyo; Gregorio Varela-Moreiras
Journal:  Nutrients       Date:  2022-05-04       Impact factor: 6.706

4.  Should we modulate the neonatal microbiome and what should be the goal?

Authors:  Niels van Best; Maria Gloria Dominguez-Bello; Mathias W Hornef; Eldin Jašarević; Katri Korpela; Trevor D Lawley
Journal:  Microbiome       Date:  2022-05-10       Impact factor: 16.837

5.  Provision of Lipid-Based Nutrient Supplements to Mothers During Pregnancy and 6 Months Postpartum and to Their Infants from 6 to 18 Months Promotes Infant Gut Microbiota Diversity at 18 Months of Age but Not Microbiota Maturation in a Rural Malawian Setting: Secondary Outcomes of a Randomized Trial.

Authors:  Arox W Kamng'ona; Rebecca Young; Charles D Arnold; Noel Patson; Josh M Jorgensen; Emma Kortekangas; David Chaima; Chikondi Malamba; Ulla Ashorn; Yin B Cheung; Per Ashorn; Kenneth Maleta; Kathryn G Dewey
Journal:  J Nutr       Date:  2020-04-01       Impact factor: 4.798

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.